| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |